Canon (7751) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Apr, 2026Executive summary
Net sales for 1Q 2026 rose 3.3% year-over-year to ¥1,093.7 billion, reaching a record high, with strong demand in Japan and Asia, and overseas sales up 4.3% while domestic sales were flat.
Operating profit declined 26.1% year-over-year to ¥71.4 billion due to higher memory costs, additional U.S. tariffs, and a shift toward lower-margin products and channels.
Net income attributable to shareholders fell 33.1% to ¥48.3 billion.
Comprehensive income increased significantly to ¥72.2 billion from ¥15.9 billion a year ago, driven by positive foreign currency translation adjustments.
Profitability was pressured by weak market conditions in the Printing Group and increased geopolitical risks, particularly in the Middle East.
Financial highlights
1Q 2026 net sales: ¥1,093.7B (+3.3% YoY); gross profit: ¥505.3B (+0.9% YoY); operating profit: ¥71.4B (-26.1% YoY); net income: ¥48.3B (-33.1% YoY).
Gross profit margin decreased to 46.2% from 47.3% YoY; operating margin fell to 6.5% from 9.1%.
Basic EPS dropped to ¥55.20 from ¥77.27 year-over-year.
Cash and cash equivalents increased to ¥639.5 billion from ¥585.9 billion at year-end 2025.
Net cash provided by operating activities fell sharply to ¥24.5 billion from ¥71.9 billion year-over-year.
Outlook and guidance
Full-year 2026 net sales projected at ¥4,765.0B (+3.0% YoY); operating profit at ¥456.0B (+0.1% YoY); net income at ¥333.0B (+0.3% YoY).
Dividend forecast maintained at ¥160 per share, targeting a payout ratio of around 40%.
Memory costs expected to negatively impact results by approximately ¥50B; further raw material and transportation cost increases not included in guidance.
FX assumptions for 2Q onward: USD/JPY 150, EUR/JPY 175.
Latest events from Canon
- Record sales and profit growth in 2025, with further gains and higher margins projected for 2026.7751
Q4 202529 Jan 2026 - Record Q2 sales and profit growth, with raised full-year outlook and strong segment results.7751
Q2 202426 Jan 2026 - Record sales and profit growth in Q3 2024, led by Printing and Imaging, with a strong full-year outlook.7751
Q3 202426 Jan 2026 - Record sales in 2024, Medical goodwill hit, but 2025 profit rebound expected.7751
Q4 202426 Jan 2026 - Record sales offset by profit pressure from tariffs; guidance lowered, dividend raised.7751
Q3 202527 Oct 2025 - Profitability improved in local currency, but full-year guidance was revised downward.7751
Q2 202524 Jul 2025 - Record Q1 sales and profit growth, led by strong imaging and printing momentum.7751
Q1 20256 Jun 2025